Low Molecular Weight Heparin Market - Size,
Share, Outlook, and Opportunity Analysis 2018-2026
Low Molecular Weight Heparins (LMWH) are a form of pharmacological anticoagulant
intervention which are derived from UFH by chemical or enzymatic depolymerisation to yield
fragments that are around one third the size of heparin. Low molecular weight heparin is used
for prophylaxis of deep vein thrombosis and pulmonary embolism, or thrombosis occurring in a
broad spectrum of clinical indications, including general or orthopaedic surgery, neurosurgery,
trauma, unstable angina, and myocardial infarction. LMWHs are However, it is associated with
higher anticoagulant effect and provides higher bioavailability after subcutaneous administration,
as compared to unfractionated heparin (UFH), for thromboembolic indications. Low molecular
weight heparin is the most suitable anticoagulant in case of complicated pregnancy, as it
eliminates risk of crossing the placental membrane.
Browse Complete Report For More Information @ http://bit.ly/2JeLsJq
The global low molecular weight heparin market size was valued at US$ 2,882.6 Mn in 2017,
and is expected to witness a CAGR of 6.7% during the forecast period (2018 – 2026).
Increasing Advantages of Low Molecular Weight Heparin over Unfractionated Heparin is
expected to drive the Market Growth during the Forecast Period
Unfractionated heparin or standard heparin varies in action from patient to patient. Thus, it can
only be administered to hospitalized patients under monitoring, while low molecular weight
heparins (LMWHs) can be used subcutaneously once a day, without requirement for monitoring.
Furthermore, LMWHs have more predictable pharmacokinetic properties as compared to
unfractionated heparin (UFH), which allows LMWHs to be administered in fixed doses and
without the need for dose adjustment based on laboratory monitoring.
Report includes chapters which deeply display the following deliverable about industry :
• Low Molecular Weight Heparin Market Research Objective and Assumption
• Low Molecular Weight Heparin Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Low Molecular Weight Heparin Market Dynamics, Regulations, and Trends Analysis - Market